Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Anti-H. pylori agents disclosed by Roussel Morishita

May 26, 1997

Novavax to initiate dose-ranging trial of Helicore

May 23, 1997

Salix reports promising clinical results for ulcerative colitis treatment

May 16, 1997

NIH announces prospective grant of licenses for IL-12 antibodies

May 16, 1997

Centocor reports results from Crohn's disease studies

May 14, 1997

Low-dose oral IFN-alpha + high-dose injectable IFN-alpha for hepatitis C

May 14, 1997

Data from U.K. phase III trial of Zacutex presented

May 13, 1997

Hepatoprotective effects of ET antagonist TAK-044

May 12, 1997

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

May 9, 1997

Tanabe licenses T-0632 to Zeria

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...